Cocarcinogenic effects of alcohol in hepatocarcinogenesis

Gut

Volumn 51, Issue 1, 2002, Pages 132-139

  Stickel, Felix ^a   Schuppan, D ^a   Hahn, E G ^a   Seitz, H K ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Krankenhaus Salem   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLIC BEVERAGE; CANCER INCIDENCE; CARCINOGENICITY; CYTOKINE RELEASE; DIET; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; EPIDEMIOLOGICAL DATA; HEPATITIS VIRUS; HUMAN; IMMUNE RESPONSE; INFECTION SENSITIVITY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METHYLATION; NONHUMAN; PATHOPHYSIOLOGY; PRECANCER; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ACETALDEHYDE; ANIMALS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; COCARCINOGENESIS; CYTOKINES; DIET; ENVIRONMENTAL POLLUTANTS; ETHANOL; HEPATITIS; HUMANS; IMMUNE TOLERANCE; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; PRECANCEROUS CONDITIONS; RETINOIDS;

EID: 0036288125     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.1.132     Document Type: Review

References (116)

1. Risk factors for the rising rates of primary liver cancer in the United States
2. Cancer incidence in five continents
3. Increase in primary liver cancer in the UK, 1979-94
4. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis
5. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
6. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma
7. Alcohol and cancer
8. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma
9. Alcohol and hepatocellular carcinoma
10. Long-term cancer risk in alcoholism
11. Chronic alcohol enhances hepatocarcinogenicity of diethylnitrosamine in rats fed a marginally methyl-deficient diet
12. Methyl groups in carcinogenesis: Effects on DNA methylation and gene expression
13. Effects of ethanol on experimental hepatocarcinogenesis
14. Experimental methods of ethanol administration
15. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy
16. Role of ethanol-inducible cytochrome P-450 2E1 in the developments of hepatocellular carcinoma by the chemical carcinogen, N-nitrosodimethylamine
17. Is Mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis
18. Appearance of oval cells in the liver of rats after long-term exposure to ethanol
19. Early histological and functional alterations of ethionine liver carcinogenesis in rats fed a choline-deficient diet
20. Oval cell numbers in human chronic liver diseases are directly related to disease severity
21. Metabolism of ethanol and higher alcohols present in alcoholic drinks and their corresponding aldehydes in subcellular components of rat esophageal mucosa, and relevance for esophageal cancer in man
22. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes
23. A case-control dietary study of primary liver cancer risk from aflatoxin exposure
24. Primary hepatic cancer in alcoholics
25. 32P-postlabelling method for the analysis of adducts arising through the reaction of acetaldehyde with 2′-deoxyguanosin-3′-monophosphate and DNA
26. The effect of chronic ethanol consumption on carcinogen metabolism and on O6-methylguanine transferase-mediated repair of alkylated DNA
27. Mutagenic, carcinogenic and teratogenic effects of alcohol
28. Working Group on the evaluation of the carcinogenic risk of chemicals to humans: Acetaldehyde
29. Alcohol and aldehyde dehydrogenase polymorphism and alcoholism
30. Catalytic properties of human liver alcohol dehydrogenase isoenzymes
31. Genetic polymorphism of alcohol dehydrogenase in Europeans: The ADH2*2 allel decreases the risk of alcoholism and is associated with ADH3*1
32. Relationship between alcohol drinking, ADH2 and ALDH2 genotypes, and risk for hepatocellular carcinoma in Japanese
33. Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P450 of rabbit liver microsomes by diverse agents: Ethanol, imidazole, trichloroethylene, acetone, pyrazole and isoniazid
34. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol
35. Effect of isoniazid (INH) on ethanol-induced lipid peroxiadtion and serum protein adduct formation
36. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole
37. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans
38. Copper dependent formation of miscoding etheno-DNA adducts in the liver of Long Evans Cinnamon (LEC) rats developping hereditary hepatitis and hepatocellular carcinoma
39. Experimental liver cirrhosis induced by alcohol and iron
40. Ethanol toxicity and nutritional status
41. Treatment of alcoholic liver disease
42. Antioxidant drugs and colchicine in the treatments of alcoholic liver disease
43. Effect of ethanol on procarcinogen activation
44. Modulation of nitrosamine metabolism by ethanol: Implications of cancer risk
45. Enhancement of dimethylnitrosamine metabolism and activation to a mutagen following chronic ethanol consumption in the rat
46. Enhanced dimethylase and dinitrosation on N-nitrosodimethylamine by human liver microsomes from alcoholics
47. Dose-response relationship for initiation of rat liver tumors by diethylnitrosamine and promotion by phenobarbitone or alcohol
48. Effect of chronic ethanol consumption on tumor incidence due to dimethylnitrosamine administration
49. Influence of ethyl alcohol on carcinogenesis induced by volatile N-nitrosamines detected in alcoholic beverages
50. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma
51. Lack of association of cytochrome P4502E1 genetic polymorphism with the risk of human hepatocellular carcinoma
52. Genetic polymorphism of cytochrome P450 2E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: A study and literature review, including meta-analysis
53. Endotoxin, endotoxin-neutralizing-capacitiy, sCD14, sICAM, and cytokines in patients with various degrees of alcoholic liver disease
54. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients
55. Circulating and tissue levels of neutrophil chemotaxin interleukin-8 are elevated in severe alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration
56. Cytokines in alcoholic and nonalcoholic steatohepatitis
57. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
58. Hepatic vitamin A depletion in alcoholic liver injury
59. A decade of molecular biology of retinoic acid receptors
60. Alcohol and retinoid metabolism
61. Alcohol, vitamin A, and beta-carotene: Adverse interactions including hepatotoxicity and carcinogenensis
62. Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-jun and c-fos) expression in rat liver
63. Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1
64. Restoration of retinoic acid concentration suppresses ethanol-enhanced c-jun expression and hepatocyte proliferation in rat liver
65. The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes
66. Alterations in DNA methylation may play a variety of roles in carcinogenesis
67. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis
68. Rapid appearance of of hypomethylated DNA in livers of rats fed cancer-promoting methyl-defient diets
69. Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma
70. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis - A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on CpG islands in microdissected specimens from patients with HCC
71. Aberrant methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis
72. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma
73. Molecular basis of multistep hepatocarcinogenesis: Genetic and epigenetic events
74. Ethanol consumption inhibits fetal DNA methylation in mice: Implications for the fetal alcohal syndrome
75. Chronic alcohol consumption induces genomic but not p53-specific DNA hypomethylation in rat colon
76. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon
77. The effect of ethanol on one-carbon metabolism: Increased methionine catabolism and methyl-group wastage
78. Effect of chronic alcohol consumption on total plasma homocysteine levels in rats
79. Vitamin B6 metbolism in chronic alcohol abuse
80. Vitamin B6 deficiency in chronic liver disease - Evidence for decreased degradation of pyridoxal-5′-phosphate
81. Anemia in alcoholics
82. Nutritional deficiencies in chronic alcoholics: Relation to dietary intake and alcohol consumption
83. The relationship of ethanol feeding to the methyl folate trap
84. Alcohol and the liver: 1994 update
85. Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration
86. Effect of alcohol drinking on gene expression of hepatic O6-methylguanine DNA methyltransferase in chronic liver diseases
87. The onset of oncagene hypomethylation in the livers of rats fed methyl-deficient, amino acid-defined diets
88. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats
89. DNA methylation is a reversible biological signal
90. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency
91. S-adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter trial
92. Viruses and alcohol in the pathogenesis of primary hepatic carcinoma
93. Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease
94. HBV-DNA hybridization in hepatocellular carcinoma associated with alcohol in Japan
95. Hepatocellular carcinoma in alcoholic liver disease: No evidence for a pathogenic role of hepatitis B virus infection
96. Hepatitis C and alcohol
97. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C
98. Hepatitis C virus infection in alcoholic liver cirrhosis in Japan: Its contribution to the development of hepatocellular carcinoma
99. Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis: A case-control study
100. Contribution of hepatitis C virus to the progression of alcoholic liver disease
101. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C
102. Increased serum hepatitis C RNA levels among alcoholic patients with chronic hepatitis C
103. Chronic hepatitis C: Effect of alcohol on hepatitic activity and viral titre
104. Functional analysis of T-cell subsets in chronic experimental alcoholism
105. Hepatic iron contents and response to to interferon-α in patients with chronic hepatitis C
106. Alcohol abuse, alcoholism, and damage to the immune system - A review
107. Effects of alcohol on immunity and cancer
108. Consequences of alcohol consumption on host defence
109. Effects of ethanol consumption on enriched natural killer cells from C57BL/6 mice
110. Ethanol decreases the number and activity of splenic natural killer cells in a mouse model for binge drinking
111. Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis
112. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcoholic liver disease but not active ethanol consumption
113. Activated CD-8 cells and HLA DR expression in alcoholics without overt liver disease
114. Serum collagen type VI and XIV, and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease
115. Effects of tranforming growth factor beta on the functions of natural killer cells: Depressed cytolytic activity and and blunting of interferon responsiveness